Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  European Journal of Pharmacology

• Publication date

  1998-10-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0014-2999(98)00664-5PMID 9845270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes.

  1998cited by this paper
• Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus.

  1997cited by this paper
• Platelet hyperaggregation in diabetic patients with different types of retinopathy is partially influenced by erythrocytes in whole blood

  1997cited by this paper
• The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus.

  1996cited by this paper
• Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes.

  1995cited by this paper
• Effects of ditazol on the vascular retinal pattern in experimental diabetes in rats.

  1995cited by this paper
• The pyrimido-pyrimidine derivatives, dipyridamole and RA-642, reduce opacification of crystalline lens in diabetic rats.

  1994cited by this paper
• Platelet-activating factor-induced enhancement of superoxide anion generation in guinea-pigs.

  1993cited by this paper
• Platelet function in diabetes mellitus.

  1992cited by this paper
• Hypersensitivity of diabetic human platelets to platelet activating factor.

  1992cited by this paper
• Effect of antiplatelet drug therapy on the retinal vascular pattern in experimental diabetes mellitus.

  1990cited by this paper
• Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitus.

  1989cited by this paper
• WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage.

  1987cited by this paper
• Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.

  1987influential reference
• Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.

  1987cited by this paper
• Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation.

  1986cited by this paper
• Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.

  1985cited by this paper
• Inositol 1,4,5-trisphosphate releases Ca2+ from a Ca2+-transporting membrane vesicle fraction derived from human platelets.

  1985cited by this paper
• The Effect of Platelet Number and Haematocrit on Whole Blood Thromboxane Synthesis

  1985cited by this paper
• Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology.

  1983cited by this paper
• Tracing Neural Connections with Horseradish Peroxidase

  1982cited by this paper
• The electronic aggregometer: a novel device for assessing platelet behavior in blood.

  1980cited by this paper

• PAF‐induced inflammatory and immuno‐allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effects

  2022cites this paper
• PLATELET ACTIVATING FACTOR IN THE EYE: PHYSIOLOGICAL ROLES, DISEASES AND FUTURE PERSPECTIVES.

  2020cites this paper
• degeneration in oxygen-induced retinopathy Role of thromboxane in retinal microvascular

  2015cites this paper
• Correlation of platelet activating factor and age-related macular degeneration

  2014cites this paper
• Ocular actions of platelet-activating factor: clinical implications

  2012cites this paper
• Tissue Biology of Proliferation and Cell Death Among Retinal Progenitor Cells

  2010cites this paper
• A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.

  2009cites this paper
• A Regulatory Role of LPCAT 1 in the Synthesis of Inflammatory Lipids , PAF and 2 LPC , in the Retina of Diabetic Mice 3 4 5

  2009cites this paper
• The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina.

  2005cites this paper
• Pharmacological approach to diabetic retinopathy.

  2004cites this paper
• Pharmacological approach to diabetic retinopathy

  2004cites this paper
• A new method to evaluate spontaneous platelet aggregation in type 2 diabetes by Cellfacts.

  2003cites this paper
• The pathogenesis of diabetic retinopathy: old concepts and new questions

  2002cites this paper
• Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy.

  2001cites this paper
• Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus.

  2000cites this paper